There are 2789 resources available
953P - Trends in disease burden from hepatocellular carcinoma: An observational study of European union 15+ countries
Presenter: Georgina Hanbury
Session: ePoster Display
954P - Comparison of medical costs and outcome between hepatectomy and radiofrequency ablation for hepatocellular carcinoma
Presenter: Takeshi Terashima
Session: ePoster Display
955P - Prognostic factor analysis of atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: Korean cancer study group (KCSG) study
Presenter: Jaekyung Cheon
Session: ePoster Display
956P - A multi-analyte liquid biopsy assay integrating cfDNA methylation and protein biomarkers for liver cancer diagnosis
Presenter: Dezhen Guo
Session: ePoster Display
966P - Diabetes therapy burden as proxy of impairment of immune checkpoint inhibitors efficacy
Presenter: Alessio Cortellini
Session: ePoster Display
967P - The time of anti-PD-1 infusion improves survival outcomes by fasting conditions simulation in non-small cell lung cancer
Presenter: Anna Vilalta
Session: ePoster Display
968P - Association between use of antibiotics (ATB) and clinical outcomes with tislelizumab (tisle) monotherapy
Presenter: Zheng-Gang Ren
Session: ePoster Display
969P - Effect of angiotensin II inhibition on non-small cell lung cancer response to immune checkpoint blockers
Presenter: Patricia Pereira
Session: ePoster Display
970P - Assessment of anti-PD-1 antibody and immune complex binding to Fcγ receptors and clinical implications
Presenter: Elena Daveri
Session: ePoster Display
971P - Is there a clinical benefit of nivolumab + ipilimumab in patients older than 75 years with advanced solid tumors?
Presenter: Thierry Landre
Session: ePoster Display